TrademarkDir
CLINTREX
LIVE

Serial Number

85906701

Owner

Clintrex, LLC

Attorney

Terria P. Jenkins

First Use Date

Jan 7, 2011

Filing Date

Apr 17, 2013

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

CLINTREX Trademark

Serial Number: 85906701 • Registration: 4561243

CLINTREX is a trademark filed by Clintrex, LLC on April 17, 2013. The trademark is classified under Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Clintrex, LLC (3 trademarks)

110 Polly Park Road
Rye, NY 10580

Entity Type: 16

CLINTREX RESEARCH CORPORATION (2 trademarks)

2 NORTH TAMIAMI TRAIL
SARASOTA, FL 34236

Entity Type: 03

CLINTREX RESEARCH, LLC

190 T C JESTER BLVD, SUITE 420
HOUSTON, TX 77007

Entity Type: 16

Trademark Details

Filing Date

April 17, 2013

Registration Date

July 1, 2014

First Use Anywhere

January 7, 2011

First Use in Commerce

January 7, 2011

Published for Opposition

September 10, 2013

Goods & Services

Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval

Conducting clinical trials for others in the field of neurodegenerative disorders

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 15, 2026 ASGN
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Aug 19, 2024 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Aug 19, 2024 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Aug 19, 2024 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 19, 2024 APRE
TEAS SECTION 8 & 9 RECEIVED
Jun 3, 2024 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jul 1, 2023 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sep 22, 2020 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sep 22, 2020 C15A
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Sep 21, 2020 EROP
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Sep 11, 2020 PR23
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 11, 2020 APRE
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Aug 19, 2020 ASGN
TEAS SECTION 8 & 15 RECEIVED
Jun 30, 2020 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 1, 2019 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 6, 2016 TCCA
REGISTERED-PRINCIPAL REGISTER
Jul 1, 2014 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 28, 2014 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 26, 2014 CNPR
STATEMENT OF USE PROCESSING COMPLETE
May 5, 2014 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 29, 2014 AITU
USE AMENDMENT FILED
Apr 9, 2014 IUAF
TEAS STATEMENT OF USE RECEIVED
Apr 9, 2014 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 5, 2013 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 10, 2013 NPUB
PUBLISHED FOR OPPOSITION
Sep 10, 2013 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 21, 2013 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 3, 2013 CNSA
ASSIGNED TO EXAMINER
Jul 31, 2013 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Apr 25, 2013 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 24, 2013 NWOS
NEW APPLICATION ENTERED
Apr 20, 2013 NWAP

Related Trademarks

More from this Owner

SMART CLINICAL TRIALS

SMART CLINICAL TRIALS

SMART CLINICAL TRIALS

SMART CLINICAL TRIALS

SMART CLINICAL TRIALS

SMART CLINICAL TRIALS

CLINTREX METHOD

CLINTREX METHOD

CLINTREX METHOD

CLINTREX METHOD

CLINTREX METHOD

CLINTREX METHOD